Literature DB >> 6345920

Plasmapheresis as a therapeutic measure in hemolytic-uremic syndrome in children.

A Gillor, M Bulla, B Roth, K Bussmann, K Schrör, A Tekook, E Gladtke.   

Abstract

Three children with hemolytic-uremic syndrome (HUS) were successfully treated with plasmapheresis (HUS) were successfully treated with plasmapheresis (PP) combined with early hemodialysis and administration of Aspirin and dipyridamole. Stimulation of vascular prostacyclin release with patients' plasma was measured before and after PP. It was reduced before and increased after plasma exchange. The data indicate that PP might be a useful tool in treatment of (HUS) in children.

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6345920     DOI： 10.1007/bf01485028

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN： 0023-2173


  19 in total

1.  [Hemolytic-uremic syndrome: bilateral necrosis of the renal cortex in acute acquired hemolytic anemia].

Authors:  C GASSER; E GAUTIER; A STECK; R E SIEBENMANN; R OECHSLIN
Journal:  Schweiz Med Wochenschr       Date:  1955-09-20

2.  Human beta-thromboglobulin inhibits PGI2 production and binds to a specific site in bovine aortic endothelial cells.

Authors:  W Hope; T J Martin; C N Chesterman; F J Morgan
Journal:  Nature       Date:  1979-11-08       Impact factor: 49.962

3.  Treatment of thrombotic thrombocytopenic purpura with plasma.

Authors:  J J Byrnes; M Khurana
Journal:  N Engl J Med       Date:  1977-12-22       Impact factor: 91.245

4.  Prostacyclin infusion in haemolytic-uraemic syndrome of children.

Authors:  T J Beattie; A V Murphy; M L Willoughby; J J Belch
Journal:  Br Med J (Clin Res Ed)       Date:  1981-08-15

5.  Combined plasmapheresis and hemodialysis treatment for severe hemolytic-uremic syndrome following Campylobacter colitis.

Authors:  T Denneberg; M Friedberg; L Holmberg; C Mathiasen; K O Nilsson; R Takolander; M Walder
Journal:  Acta Paediatr Scand       Date:  1982-03

6.  Preliminary report: treatment of the hemolytic-uremic syndrome with aspirin and dipyridamole.

Authors:  E B Arenson; C S August
Journal:  J Pediatr       Date:  1975-06       Impact factor: 4.406

7.  Reversible deficient prostacyclin release in childhood hemolytic uremic syndrome.

Authors:  D A Chamone; W C Proesmans; L A Monnens; P Binda ki Muaka; J G Vermylen
Journal:  Int J Pediatr Nephrol       Date:  1982-03

8.  Haemolytic-uraemic syndrome: deficiency of plasma factor(s) regulating prostacyclin activity?

Authors:  G Remuzzi; R Misiani; D Marchesi; M Livio; G Mecca; G de Gaetano; M B Donati
Journal:  Lancet       Date:  1978-10-21       Impact factor: 79.321

9.  Treatment of the hemolytic uremic syndrome with plasma.

Authors:  G Remuzzi; R Misiani; D Marchesi; M Livio; G Mecca; G de Gaetano; M D Donati
Journal:  Clin Nephrol       Date:  1979-12       Impact factor: 0.975

10.  Different sensitivities of prostaglandin-cyclooxygenases in blood platelets and coronary arteries against non-steroidal antiinflammatory drugs.

Authors:  K Schrör; S Sauerland; A Kuhn; R Rösen
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1980-08       Impact factor: 3.000
View more
  1 in total

1.  Deficiency of antithrombin III in children with hemolytic-uremic syndrome.

Authors:  B Roth; T von Lilien; B Busch; A Gillor; M Bulla
Journal:  Eur J Pediatr       Date:  1984-04       Impact factor: 3.183
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.